Short Interest in AirSculpt Technologies, Inc. (NASDAQ:AIRS) Rises By 12.1%

AirSculpt Technologies, Inc. (NASDAQ:AIRS) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 2,040,000 shares, an increase of 12.1% from the November 15th total of 1,820,000 shares. Based on an average daily volume of 169,600 shares, the short-interest ratio is presently 12.0 days. Currently, 16.7% of the shares of the stock are sold short.

Wall Street Analysts Forecast Growth

Separately, BTIG Research initiated coverage on shares of AirSculpt Technologies in a report on Thursday, October 17th. They issued a “neutral” rating on the stock.

Insider Buying and Selling

In related news, CEO Dennis Dean sold 7,719 shares of AirSculpt Technologies stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $7.53, for a total transaction of $58,124.07. Following the transaction, the chief executive officer now directly owns 628,940 shares of the company’s stock, valued at $4,735,918.20. The trade was a 1.21 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 78.77% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On AirSculpt Technologies

A number of large investors have recently made changes to their positions in the company. Barclays PLC boosted its stake in AirSculpt Technologies by 227.0% in the 3rd quarter. Barclays PLC now owns 19,100 shares of the company’s stock worth $97,000 after purchasing an additional 13,259 shares during the period. Geode Capital Management LLC grew its holdings in shares of AirSculpt Technologies by 6.4% during the third quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after buying an additional 21,339 shares in the last quarter. Vanguard Group Inc. raised its position in AirSculpt Technologies by 1.0% during the first quarter. Vanguard Group Inc. now owns 576,038 shares of the company’s stock valued at $3,537,000 after buying an additional 5,606 shares during the period. Finally, SW Investment Management LLC lifted its stake in AirSculpt Technologies by 5.0% in the 2nd quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock worth $18,000,000 after acquiring an additional 213,677 shares in the last quarter. Institutional investors and hedge funds own 91.54% of the company’s stock.

AirSculpt Technologies Stock Performance

Shares of NASDAQ AIRS opened at $5.68 on Friday. The stock’s fifty day simple moving average is $6.37 and its 200 day simple moving average is $5.02. The stock has a market capitalization of $328.76 million, a price-to-earnings ratio of -40.57 and a beta of 1.64. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.80. AirSculpt Technologies has a 52-week low of $2.92 and a 52-week high of $9.20.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings results on Friday, November 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). AirSculpt Technologies had a positive return on equity of 2.22% and a negative net margin of 4.13%. The company had revenue of $42.55 million during the quarter, compared to analysts’ expectations of $42.49 million. During the same period in the prior year, the business posted ($0.01) EPS. As a group, sell-side analysts forecast that AirSculpt Technologies will post 0.08 earnings per share for the current fiscal year.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.